(Q34218569)

English

Meningococcal vaccines

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

Meningococcal vaccines. (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Rosenstein NE

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Fischer M

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Tappero JW

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Infectious Disease Clinics of North America

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

155-169

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Transferrin receptors of Neisseria meningitidis: promising candidates for a broadly cross-protective vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Meningococcal disease prevention and control strategies for practice-based physicians (Addendum: recommendations for college students). Committee on Infectious Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Tetravalent meningococcal polysaccharide vaccine groups A, C, Y, W 135: clinical and serological evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of Meningococcal Disease by Group C Polysaccharide Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Failure of meningococcal vaccination to stop the transmission of meningococci in Nigerian schoolboys

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies to poly[(2----8)-alpha-N-acetylneuraminic acid] and poly[(2----9)-alpha-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Meningococcal disease in college students

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Meningococcal vaccine development: a novel approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Preclinical evaluation of a novel group B meningococcal conjugate vaccine that elicits bactericidal activity in both mice and nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection of an immunogenic peptide mimic of the capsular polysaccharide of Neisseria meningitidis serogroup A using a peptide display library

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of meningococcal infection in college students.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Meningococcal carriage, meningococcal disease and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immune response to a peptide mimic of Neisseria meningitidis serogroup C in hu-PBMC-SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Endogenous sialylation of the lipooligosaccharides of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Group A meningococcal carriage in travelers returning from Saudi Arabia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigen-specific T-cell responses in humans after intranasal immunization with a meningococcal serogroup B outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemic meningococcal disease in Nairobi, Kenya, 1989. The Kenya/Centers for Disease Control (CDC) Meningitis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology and prevention of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

"Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of recombinant transferrin-binding protein B variants from Neisseria meningitidis for their ability to induce cross-reactive and bactericidal antibodies against a genetically diverse collection of serogroup B strains

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The 5C protein of Neisseria meningitidis is highly immunogenic in humans and induces bactericidal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of meningococcal vaccine and barriers to vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Bacterial meningitis in the United States in 1995. Active Surveillance Team

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

For discussion: live attenuated vaccines for group B meningococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of the Opc protein correlates with invasion of epithelial and endothelial cells by Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

New strategies for using mucosal vaccination to achieve more effective immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Serogroup B meningococcal disease: new outbreaks, new strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergency vaccination against epidemic meningitis in Ghana: Implications for the control of meningococcal disease in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunologic response of man to group B meningococcal polysaccharide vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of vaccines containing meningococcal group B polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970273-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0891-5520(05)70273-7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34218569&oldid=1983471080"